Epidemiology of Sexually Transmitted Infections and Its iMpAcT on fEmale Infertility
Launched by UNIVERSITY OF LUEBECK · Feb 8, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying sexually transmitted infections (STIs) and how they may affect fertility in young women. The researchers want to understand how common these infections are among women aged 18 to 22 and explore how the bacteria in the female genital tract might influence fertility. By gathering this information, they hope to learn more about how STIs could impact women’s ability to have children.
To participate in this study, women must be between 18 and 22 years old and able to give their consent to join. It's important to note that women who are currently pregnant, have had sterilization (a procedure to prevent pregnancy), or are unable to provide informed consent cannot take part in the trial. Participants can expect to be involved in a long-term study, where they will share information about their health and any STIs they may have. This research is important, as it aims to improve our understanding of STIs and fertility, ultimately helping to support women's health.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 18-22 years
- • informed consent
- Exclusion Criteria:
- • pregnancy
- • sterilization
- • not capable of giving informed consent
About University Of Luebeck
The University of Lübeck is a renowned academic institution in Germany, recognized for its commitment to advancing medical research and education. With a strong focus on innovative clinical trials, the university leverages its interdisciplinary expertise to explore novel therapeutic approaches and enhance patient care. The institution fosters collaboration among researchers, clinicians, and industry partners, ensuring a robust framework for conducting high-quality studies. Through its clinical trial initiatives, the University of Lübeck aims to translate scientific discoveries into tangible health solutions, contributing to the global advancement of medical knowledge and practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lübeck, , Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials